C. Mavragani

428 total citations
7 papers, 231 citations indexed

About

C. Mavragani is a scholar working on Rheumatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, C. Mavragani has authored 7 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 3 papers in Pathology and Forensic Medicine and 3 papers in Epidemiology. Recurrent topics in C. Mavragani's work include Systemic Sclerosis and Related Diseases (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Urticaria and Related Conditions (2 papers). C. Mavragani is often cited by papers focused on Systemic Sclerosis and Related Diseases (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Urticaria and Related Conditions (2 papers). C. Mavragani collaborates with scholars based in Greece, United States and Sweden. C. Mavragani's co-authors include Maryam Dastmalchi, Helene Alexanderson, Sevim Barbasso Helmers, Kerstin Elvin, Cecilia Grundtman, Inger Nennesmo, Mary K. Crow, Ingrid E. Lundberg, H Einarsdottir and Haralampos Μ. Moutsopoulos and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Lupus.

In The Last Decade

C. Mavragani

7 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Mavragani Greece	4	161	131	59	50	28	7	231
Esthela Loyo United States	7	102 0.6×	130 1.0×	83 1.4×	33 0.7×	21 0.8×	9	268
Robert P New United Kingdom	4	199 1.2×	108 0.8×	41 0.7×	41 0.8×	43 1.5×	10	267
Lesly‐Anne Samedy United States	4	203 1.3×	152 1.2×	59 1.0×	49 1.0×	37 1.3×	6	250
Angeles S. Galindo‐Feria Sweden	10	191 1.2×	76 0.6×	73 1.2×	38 0.8×	68 2.4×	21	264
I. M. Bronner Netherlands	6	224 1.4×	99 0.8×	30 0.5×	44 0.9×	70 2.5×	8	256
L. Bolko France	8	173 1.1×	141 1.1×	75 1.3×	33 0.7×	84 3.0×	20	320
Anke Rietveld Netherlands	7	206 1.3×	144 1.1×	97 1.6×	35 0.7×	64 2.3×	11	309
S. Josse France	6	299 1.9×	144 1.1×	35 0.6×	50 1.0×	52 1.9×	10	357
M. F. G. van der Meulen Netherlands	8	266 1.7×	120 0.9×	38 0.6×	48 1.0×	86 3.1×	9	301
Arash H. Lahouti United States	7	194 1.2×	72 0.5×	29 0.5×	39 0.8×	61 2.2×	12	239

Countries citing papers authored by C. Mavragani

Since Specialization

Citations

This map shows the geographic impact of C. Mavragani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Mavragani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Mavragani more than expected).

Fields of papers citing papers by C. Mavragani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Mavragani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Mavragani. The network helps show where C. Mavragani may publish in the future.

Co-authorship network of co-authors of C. Mavragani

This figure shows the co-authorship network connecting the top 25 collaborators of C. Mavragani. A scholar is included among the top collaborators of C. Mavragani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Mavragani. C. Mavragani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Nezos, Adrianos, et al.. (2017). THU0028 Type i interferon signature in the peripheral blood and CXCL4 plasma levels in patients with systemic sclerosis. Annals of the Rheumatic Diseases. 76. 210–210. 1 indexed citations

2.

Mavragani, C., G. Fragoulis, D. Rontogianni, Maria Kanariou, & Haralampos Μ. Moutsopoulos. (2013). THU0325 Elevated IgG4 Serum Levels Among Primary Sjogren's Syndrome Patients: Do they Unmask Underlying IgG4-Related Disease?. Annals of the Rheumatic Diseases. 72. A275–A275. 1 indexed citations

3.

Danielides, Stamatina, et al.. (2011). Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma. Scandinavian Journal of Rheumatology. 40(4). 299–303. 8 indexed citations

4.

Mavragani, C., et al.. (2009). Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations. Lupus. 18(12). 1096–1099. 13 indexed citations

5.

Dastmalchi, Maryam, Cecilia Grundtman, Helene Alexanderson, et al.. (2008). A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Annals of the Rheumatic Diseases. 67(12). 1670–1677. 180 indexed citations

6.

Mavragani, C. & H M Moutsopoulos. (2005). Immunsuppression und Immunmodulation beim Sjögren-Syndrom - Was ist bewiesen? Lindert sie die Sicca-Symptome?. Aktuelle Rheumatologie. 30(1). 66–70. 1 indexed citations

7.

Mavragani, C., et al.. (1999). Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. Lara D. Veeken. 38(12). 1228–1233. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact